nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—SLC22A5—Dactinomycin—ocular cancer	0.774	1	CbGbCtD
Norfloxacin—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.0101	0.0446	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.00985	0.0436	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.00985	0.0436	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.00966	0.0428	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.00887	0.0393	CbGpPWpGaD
Norfloxacin—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.00875	0.0388	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.00838	0.0371	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.00797	0.0353	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.00779	0.0345	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.00452	0.02	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.00372	0.0165	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00356	0.0158	CbGpPWpGaD
Norfloxacin—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.00321	0.0142	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00314	0.0139	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00309	0.0137	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00309	0.0137	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00294	0.013	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00287	0.0127	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.00261	0.0116	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.0026	0.0115	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00256	0.0113	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00256	0.0113	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.00251	0.0111	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.00251	0.0111	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.0023	0.0102	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.00228	0.0101	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00217	0.00963	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00217	0.00963	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00207	0.00916	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.00203	0.00901	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00202	0.00895	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00194	0.00859	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00194	0.00858	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0019	0.00841	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00183	0.00812	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00167	0.00739	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00137	0.00608	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00137	0.00605	CbGpPWpGaD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00136	0.00601	CbGpPWpGaD
Norfloxacin—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.00132	0.00586	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00118	0.00524	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00117	0.0052	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00117	0.0052	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00115	0.0051	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00112	0.00496	CbGpPWpGaD
Norfloxacin—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.00109	0.00481	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00105	0.00466	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.00103	0.00456	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00102	0.00451	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000973	0.00431	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000966	0.00428	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.000957	0.00424	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.000947	0.0042	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.000942	0.00417	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000938	0.00415	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000938	0.00415	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00092	0.00407	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00092	0.00407	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—E2F5—ocular cancer	0.000856	0.00379	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.000854	0.00378	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000844	0.00374	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.000838	0.00371	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.000838	0.00371	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000833	0.00369	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00083	0.00367	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.000822	0.00364	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.000822	0.00364	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.000813	0.0036	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000797	0.00353	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000797	0.00353	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000797	0.00353	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000787	0.00349	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000758	0.00336	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000757	0.00336	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.000755	0.00334	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000741	0.00328	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000732	0.00324	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000723	0.0032	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.000713	0.00316	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.000713	0.00316	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000699	0.0031	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000685	0.00303	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.000678	0.003	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000672	0.00298	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000668	0.00296	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.000663	0.00294	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000631	0.0028	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.000601	0.00266	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.000601	0.00266	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000596	0.00264	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00058	0.00257	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.000573	0.00254	CbGpPWpGaD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—TP53—ocular cancer	0.000572	0.00253	CbGpPWpGaD
Norfloxacin—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.000569	0.00252	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000533	0.00236	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00052	0.0023	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00052	0.0023	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.000518	0.0023	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000508	0.00225	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000501	0.00222	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000492	0.00218	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00048	0.00213	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000476	0.00211	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000457	0.00202	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000457	0.00202	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK6—ocular cancer	0.000448	0.00198	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000442	0.00196	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000431	0.00191	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000431	0.00191	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000426	0.00189	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000408	0.00181	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000404	0.00179	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000398	0.00176	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000397	0.00176	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000386	0.00171	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000385	0.00171	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND2—ocular cancer	0.000385	0.00171	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.000385	0.00171	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSPH—ocular cancer	0.000379	0.00168	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000373	0.00165	CbGpPWpGaD
Norfloxacin—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.000363	0.00161	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000355	0.00157	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000354	0.00157	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSPH—ocular cancer	0.000347	0.00154	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.000345	0.00153	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.00034	0.00151	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.000332	0.00147	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000332	0.00147	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—E2F1—ocular cancer	0.000317	0.0014	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000312	0.00138	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000309	0.00137	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000308	0.00137	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000306	0.00136	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000306	0.00135	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000291	0.00129	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000291	0.00129	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000289	0.00128	CbGpPWpGaD
Norfloxacin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00028	0.00124	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSPH—ocular cancer	0.000274	0.00121	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK2—ocular cancer	0.000273	0.00121	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSPH—ocular cancer	0.000259	0.00115	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK4—ocular cancer	0.000258	0.00114	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000254	0.00112	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000254	0.00112	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000253	0.00112	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.000251	0.00111	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.000244	0.00108	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.000227	0.00101	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—RB1—ocular cancer	0.000225	0.000995	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000222	0.000985	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000214	0.000949	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—TGFB1—ocular cancer	0.000211	0.000937	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000199	0.000883	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000195	0.000866	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MDM2—ocular cancer	0.000191	0.000848	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000186	0.000826	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.00018	0.000799	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.000175	0.000774	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.000172	0.00076	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000167	0.000739	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSPH—ocular cancer	0.000165	0.00073	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000161	0.000715	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—EP300—ocular cancer	0.000153	0.00068	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000153	0.000679	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.00015	0.000663	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—ocular cancer	0.000134	0.000592	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSPH—ocular cancer	0.000127	0.000564	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GNA11—ocular cancer	0.000119	0.000528	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GNAQ—ocular cancer	0.000111	0.000491	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—ocular cancer	0.00011	0.000487	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GNA11—ocular cancer	0.000109	0.000484	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GNAQ—ocular cancer	0.000102	0.00045	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GNA11—ocular cancer	8.61e-05	0.000381	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GNA11—ocular cancer	8.14e-05	0.00036	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GNAQ—ocular cancer	8.01e-05	0.000355	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GNAQ—ocular cancer	7.56e-05	0.000335	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.1e-05	0.00027	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GNA11—ocular cancer	5.19e-05	0.00023	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GNAQ—ocular cancer	4.82e-05	0.000214	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GNA11—ocular cancer	4e-05	0.000177	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—EP300—ocular cancer	3.98e-05	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.89e-05	0.000172	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GNAQ—ocular cancer	3.72e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—EP300—ocular cancer	3.65e-05	0.000162	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—EP300—ocular cancer	2.88e-05	0.000127	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—EP300—ocular cancer	2.72e-05	0.00012	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—ocular cancer	2.41e-05	0.000107	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—ocular cancer	2.2e-05	9.77e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—ocular cancer	1.74e-05	7.7e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EP300—ocular cancer	1.73e-05	7.68e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—ocular cancer	1.64e-05	7.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EP300—ocular cancer	1.34e-05	5.93e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—ocular cancer	1.05e-05	4.64e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—ocular cancer	8.08e-06	3.58e-05	CbGpPWpGaD
